All
Cancer Survivors Face Cardiovascular Health and Mortality Disparities
June 23rd 2023Factors including race, insurance and treatment history have been associated with increased cardiovascular disease, risk factors and mortality among cancer survivors, including those with a history of pediatric cancer, according to recent research.
Adding Tecentriq to Cabometyx Doesn’t Improve Advanced RCC Outcomes
June 22nd 2023The addition of Tecentriq to Cabometyx did not improve the length of time patients lived without their disease getting worse for individuals with previously treated advanced kidney cancer, and came with additional side effects, too, recent research showed.